Changzhou Branch of BGI Research (Changdanghu Institute of Engineering Biology, BGI) is located in Jintan District, Changzhou. Phase I of the project has a floor area of approximately 6,300 m², with a total construction investment of about RMB 150 million, and Phase II construction investment of RMB 200 million. The Changzhou Branch will be based on major scientific and technological and industrial frontiers, and will build a high-throughput large-scale platform using high-throughput synthesizers based on independently owned intellectual property innovation principles. Leveraging the biological industry ecosystem advantages of the Biopharmaceutical Industry Park in Jintan District, Changzhou, it will advance the rapid development of bio-intelligent manufacturing, biopharmaceuticals and other industries through high-throughput, low-cost, high-quality DNA synthesis capabilities. At the same time, the Branch will focus on core technologies across the upstream, midstream and downstream industrial chain of synthetic biology, including R&D of key DNA synthesis and assembly technologies and development of core tools, and self-production of key upstream raw materials, to solve bottleneck problems; carry out frontier research integrating BT and IT, including product development and industrial incubation with promising industrialization application prospects such as artificial chassis cell construction, antibody development, mRNA vaccines, nucleic acid and peptide drugs, and novel big data storage.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows